Tuesday, January 24, 2023

< + > The End Of Obesity

Since its 2021 launch, Novo Nordisk’s Wegovy set the stage for the next generation of anti-obesity drugs that target the gut’s weight-regulating mechanisms. Now, a new drug on the scene promises to be more effective and safer than any other weight loss drug before.

No comments:

Post a Comment

< + > Bonus Features – April 12, 2026 – 67% of consumers say AI’s time savings will make providers more engaged, 27% of desktop devices in healthcare are unencrypted, plus 25 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...